drug-discovery

Retrieve bioactivity and drug-likeness data from ChEMBL, PubChem, and OpenFDA APIs.

19|4|Updated Apr 22, 2026
One-click install
npx skills add https://github.com/carterwayneskhizeine/hermes-agent-windows-R --skill drug-discovery-carterwayneskhizeine
Or copy as Structured Prompt for Agent
Please help me install this Agent Skill.
Skill: drug-discovery
Source: https://github.com/carterwayneskhizeine/hermes-agent-windows-R/tree/main/optional-skills/research/drug-discovery
Command: npx skills add https://github.com/carterwayneskhizeine/hermes-agent-windows-R --skill drug-discovery-carterwayneskhizeine

SYSTEM DOCUMENTATION & REQUIREMENTS

💡 This Skill includes scripts (resource) and references (resource) components.

What problem does it solve?

This Skill helps you research drug discovery candidates by quickly pulling bioactivity data, estimating drug-likeness, and summarizing interaction and safety signals from public sources.

Core Features & Use Cases

  • Bioactive compound and target search (ChEMBL): Find targets, retrieve top active molecules, and inspect molecule-level properties.
  • Drug-likeness screening (PubChem + rule sets): Compute practical property summaries and apply Lipinski Ro5 and Veber oral bioavailability checks.
  • Interaction and safety lookups (OpenFDA): Retrieve label-reported drug–drug interactions and adverse event mentions to support early risk triage.
  • ADMET-style reasoning support: Use the provided ADMET reference to interpret absorption, distribution, metabolism, excretion, and toxicity themes during lead optimization discussions.
  • Use Case: When you have a lead molecule name or an EGFR target concept, you can fetch candidate bioactivity context from ChEMBL, run Ro5/Veber-style assessments from PubChem, and then query OpenFDA for interaction/safety signals relevant to your compound or drug candidate.

Quick Start

Use the drug-discovery skill to evaluate a compound's oral-likeness by running it for the molecule name you are investigating (e.g., aspirin).

Frequently Asked Questions about drug-discovery

High-intent search queries and answers about installing and using this skill.

FAQPage Schema
How do I check drug-likeness using Lipinski Ro5 and Veber rules for a compound?

Check drug-likeness by retrieving molecular properties from PubChem and applying Lipinski Ro5 and Veber oral bioavailability rules via bundled Python scripts to compute property thresholds.

How do I retrieve bioactivity data for drug discovery targets from ChEMBL?

Retrieve bioactivity data by querying the ChEMBL API to find targets, fetch top active molecules, and inspect molecule-level properties for medicinal chemistry workflows.

Can I use OpenFDA to look up drug interactions and adverse events for early ADMET triage?

Use OpenFDA to query label-reported drug interactions and adverse event mentions, providing safety summaries that support early ADMET risk triage for drug candidates.

What is the best way to evaluate a lead molecule's oral bioavailability before lead optimization?

Evaluate oral bioavailability by pulling molecular properties from PubChem and running rule-based drug-likeness screenings using Lipinski Ro5 and Veber parameters against computed thresholds.

Do I need Python to compute molecular property thresholds for cheminformatics screening?

Python is optional but supported through bundled helper scripts that compute and report property thresholds, while core data retrieval relies on executing curl-backed API calls.

Are there limitations to using public chemical APIs for early drug discovery workflows?

Limitations include dependency on public API availability for ChEMBL, PubChem, and OpenFDA, meaning data retrieval requires network access and rule-based screening serves only early triage rather than definitive ADMET conclusions.